The global Cytotoxic Drugs Contract Manufacturing Market Growth Accelerated by Increasing Prevalence of Cancer

Cytotoxic drugs play a vital role in the treatment of various types of cancers such as lung cancer, breast cancer, leukemia, lymphoma, and others. These drugs work by preventing or slowing the growth of cancer cells in the body. Increasing prevalence of cancer worldwide drives the demand for cytotoxic drugs for treatment. Cytotoxic drugs manufacturers are focusing on contract manufacturing to meet the bulk production requirements for these drugs in a cost-effective manner. The global Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at US$ 6,285.2 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The increasing prevalence of cancer has been a major driver of the cytotoxic drugs contract manufacturing market. As per the World Health Organization (WHO), cancer is the second leading cause of death globally and was responsible for nearly 10 million deaths in 2020. The four most common types of cancer that account for over half of all new cancer cases include lung cancer, breast cancer, colorectal cancer, and prostate cancer. With the rising incidence of cancer worldwide, the demand for chemotherapy drugs such as cytotoxic drugs is also increasing significantly. This is expected to boost the growth of the cytotoxic drugs contract manufacturing market over the forecast period. The focus of major market players on contract manufacturing of these drugs to meet large scale production requirements cost-effectively will further support market growth.

Segment Analysis     
The global cytotoxix drugs contract manufacturing market is dominated by the solid dosage forms segment. This segment accounted for the largest market share in 2023 owing to the high demand for tablet and capsule dosage forms for cytotoxic drug therapies. Solid dosage forms offer advantages like ease of administration and accurate dosing which has made them the preferred form for most cytotoxic drug therapies.

Key Takeaways
The global cytotoxix drugs contract manufacturing market is expected to witness high growth over the forecast period of 2023 to 2030.  The global Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at US$ 6,285.2 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030.

Regional analysis
North America currently dominates the global cytotoxix drugs contract manufacturing market with the highest market share. This can be attributed to factors like strong pharmaceutical industry, high healthcare expenditure and presence of leading contract manufacturing organizations in the region. However, Asia Pacific is expected to grow at the fastest pace during the forecast period due to growing pharmaceutical industry, availability of low cost manufacturing options and increasing biologics and biosimilars production in the region.

Key players

Key players operating in the cytotoxix drugs contract manufacturing market are Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma Internatisonal, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group. Lonza Group and Piramal Group currently dominate the market due to their large production capacities and wide service portfolios for cytotoxix drug manufacturing.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more